Source: Journal of the American Society of Nephrology. Conference titles: Annual Meeting and 1999 Renal Week. Unidade: FM
Assunto: PATOLOGIA
ABNT
ARAUJO, M. R. T. et al. Mycophenolate mofetil (MMF) in the treatment of chronic renal allograft rejection: a three-year follow-up. Journal of the American Society of Nephrology. Florida: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 out. 2024. , 1999APA
Araujo, M. R. T., Oliveira, A. C., Abensur, H., Marcondes, M., Romao Jr., J. E., Zatz, R., & Noronha, I. L. (1999). Mycophenolate mofetil (MMF) in the treatment of chronic renal allograft rejection: a three-year follow-up. Journal of the American Society of Nephrology. Florida: Faculdade de Medicina, Universidade de São Paulo.NLM
Araujo MRT, Oliveira AC, Abensur H, Marcondes M, Romao Jr. JE, Zatz R, Noronha IL. Mycophenolate mofetil (MMF) in the treatment of chronic renal allograft rejection: a three-year follow-up. Journal of the American Society of Nephrology. 1999 ; 10 719A res. A 3640.[citado 2024 out. 10 ]Vancouver
Araujo MRT, Oliveira AC, Abensur H, Marcondes M, Romao Jr. JE, Zatz R, Noronha IL. Mycophenolate mofetil (MMF) in the treatment of chronic renal allograft rejection: a three-year follow-up. Journal of the American Society of Nephrology. 1999 ; 10 719A res. A 3640.[citado 2024 out. 10 ]